73 related articles for article (PubMed ID: 16951146)
21. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
22. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
Lin CY; Ström A; Li Kong S; Kietz S; Thomsen JS; Tee JB; Vega VB; Miller LD; Smeds J; Bergh J; Gustafsson JA; Liu ET
Breast Cancer Res; 2007; 9(2):R25. PubMed ID: 17428314
[TBL] [Abstract][Full Text] [Related]
24. Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
Chu I; Arnaout A; Loiseau S; Sun J; Seth A; McMahon C; Chun K; Hennessy B; Mills GB; Nawaz Z; Slingerland JM
J Clin Invest; 2007 Aug; 117(8):2205-15. PubMed ID: 17627304
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
Sabnis G; Goloubeva O; Jelovac D; Schayowitz A; Brodie A
Clin Cancer Res; 2007 May; 13(9):2751-7. PubMed ID: 17473209
[TBL] [Abstract][Full Text] [Related]
26. Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?
Murphy LC; Watson PH
Endocr Relat Cancer; 2006 Jun; 13(2):327-34. PubMed ID: 16728566
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients.
Seow HF; Yip WK; Loh HW; Ithnin H; Por P; Rohaizak M
Pathol Oncol Res; 2010 Jun; 16(2):239-48. PubMed ID: 19882362
[TBL] [Abstract][Full Text] [Related]
28. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1.
Frigo DE; Basu A; Nierth-Simpson EN; Weldon CB; Dugan CM; Elliott S; Collins-Burow BM; Salvo VA; Zhu Y; Melnik LI; Lopez GN; Kushner PJ; Curiel TJ; Rowan BG; McLachlan JA; Burow ME
Mol Endocrinol; 2006 May; 20(5):971-83. PubMed ID: 16410316
[TBL] [Abstract][Full Text] [Related]
29. PI3K-based molecular signatures link high PI3K pathway activity with low ER levels in ER+ breast cancer.
Sanchez A; Villanueva J
Expert Rev Proteomics; 2010 Dec; 7(6):819-21. PubMed ID: 21142884
[TBL] [Abstract][Full Text] [Related]
30. ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.
Dong XY; Sun X; Guo P; Li Q; Sasahara M; Ishii Y; Dong JT
J Biol Chem; 2010 Oct; 285(43):32801-32809. PubMed ID: 20720010
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta and breast cancer.
Balfe PJ; McCann AH; Welch HM; Kerin MJ
Eur J Surg Oncol; 2004 Dec; 30(10):1043-50. PubMed ID: 15522549
[TBL] [Abstract][Full Text] [Related]
32. Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer.
Castel P; Toska E
Mol Cell Oncol; 2019; 6(6):e1625620. PubMed ID: 31692833
[TBL] [Abstract][Full Text] [Related]
33. Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT).
Robertson JFR; Coleman RE; Cheung KL; Evans A; Holcombe C; Skene A; Rea D; Ahmed S; Jahan A; Horgan K; Rauchhaus P; Littleford R; Amy Cheung SY; Cullberg M; de Bruin EC; Koulai L; Lindemann JPO; Pass M; Rugman P; Schiavon G; Deb R; Finlay P; Foxley A; Gee JMW
Clin Cancer Res; 2022 Dec; 28(24):5469. PubMed ID: 36519303
[No Abstract] [Full Text] [Related]
34. Correction: Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy.
Mimouna S; Rollins DA; Shibu G; Tharmalingam B; Deochand DK; Chen X; Oliver D; Chinenov Y; Rogatsky I
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33226409
[No Abstract] [Full Text] [Related]
35. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
36. Estrogen's sex-specific effects on ischemic cell death and estrogen receptor mRNA expression in rat cortical organotypic explants.
Trout AL; McLouth CJ; Westberry JM; Sengoku T; Wilson ME
Aging Brain; 2024; 5():100117. PubMed ID: 38650743
[TBL] [Abstract][Full Text] [Related]
37. Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis.
Park Y; Cho YJ; Sung N; Park MJ; Guan X; Gibbons WE; O'Malley BW; Han SJ
J Biomed Sci; 2022 Nov; 29(1):100. PubMed ID: 36419064
[TBL] [Abstract][Full Text] [Related]
38. Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
van Barele M; Heemskerk-Gerritsen BAM; Louwers YV; Vastbinder MB; Martens JWM; Hooning MJ; Jager A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34063736
[TBL] [Abstract][Full Text] [Related]
39. Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer.
Sellitto A; D'Agostino Y; Alexandrova E; Lamberti J; Pecoraro G; Memoli D; Rocco D; Coviello E; Giurato G; Nassa G; Tarallo R; Weisz A; Rizzo F
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32516978
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
